Annexon biosciences to participate in the 21st annual needham virtual healthcare conference

Cambridge, mass., april 04, 2022 (globe newswire) -- annexon, inc. (nasdaq: annx), a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative and ophthalmic disorders, today announced that douglas love, esq., president & chief executive officer, will participate in a fireside chat at the 21st annual needham virtual healthcare conference on monday, april 11, 2022 at 3:45 p.m. et.
ANNX Ratings Summary
ANNX Quant Ranking